Glipizide
Back to searchMolecule Structure
Scientific Name
Glipizide
Description of the Drug
Glipizide is a sulfonylurea medication used in Type 2 Diabetes to sensitize pancreatic beta cells and stimulate insulin release.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01067
http://www.drugbank.ca/drugs/DB01067
Brand Name(s)
Glibenese, Glipizide, Glucotrol, Glucotrol xl, Minodiab 2.5, Minodiab 5
Company Owner(s)
Sun Pharmaceutical Industries Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd, Accord Healthcare Inc, Ani Pharmaceuticals Inc, Aurobindo Pharma Ltd, Beximco Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sulfonylurea receptor 1, Kir6.2 | PROTEIN COMPLEX | BLOCKER | CHEMBL2096972 |
Clinical Trial(s)
Unichem Links
| Atlas | glipizide | |
| SureChEMBL | SCHEMBL17094 | |
| PharmGKB | PA449762 | |
| Human Metabolome Database | HMDB0015200 | |
| DrugBank | DB01067 | |
| PubChem: Thomson Pharma | 14906210 | |
| PubChem | 3478 | |
| Mcule | MCULE-5142805548 | |
| LINCS | LSM-2251 | |
| Nikkaji | J20.336J | |
| BindingDB | 50012956 | |
| EPA CompTox Dashboard | DTXSID0040676 | |
| DrugCentral | 1301 | |
| Brenda | 88880 | |
| ChemicalBook | CB9185001 | |
| Guide to Pharmacology | 6821 | |
| rxnorm | GLIPIZIDE | GLUCOTROL |
| ChEBI | 5384 | |
| ZINC | ZINC000000537795 |
